Johnson & Johnson News

JOHNSON &JOHNSON: Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (daratumumab) Split Dosing Regimen

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S.

JOHNSON & JOHNSON: Johnson & Johnson to Participate in the 2018 Wells Fargo 13th Annual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Wells Fargo 13th Annual Healthcare Conference on Thursday, Sept. 6th, at The Westin Boston Waterfront in Boston, MA.

JOHNSON & JOHNSON: Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Consumer Staples Conference on Thursday, Sept. 6th, at the InterContinental, Boston, MA.

JOHNSON & JOHNSON: Johnson & Johnson Announces Series of Collaborations Aimed at Transforming Mental Health Care in Low-Resource Settings

Johnson & Johnson Services Inc. (Johnson & Johnson) announced today a comprehensive partnership with the Government of Rwanda to significantly strengthen and expand access to quality mental health care in the country.

Metro Business Network